|
PSMA1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.787400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.086000E-01 |
| Normal-vs-Stage2 |
4.730400E-02 |
| Normal-vs-Stage3 |
2.751600E-01 |
| Normal-vs-Stage4 |
2.968800E-01 |
| Stage1-vs-Stage2 |
4.356000E-02 |
| Stage1-vs-Stage3 |
2.472600E-01 |
| Stage1-vs-Stage4 |
3.391800E-01 |
| Stage2-vs-Stage3 |
3.262400E-01 |
| Stage2-vs-Stage4 |
3.481200E-01 |
| Stage3-vs-Stage4 |
9.712800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.194800E-01 |
| Normal-vs-AfricanAmerican |
6.315000E-01 |
| Normal-vs-Asian |
3.688000E-01 |
| Caucasian-vs-AfricanAmerican |
2.792000E-01 |
| Caucasian-vs-Asian |
8.877800E-02 |
| AfricanAmerican-vs-Asian |
8.604200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.106200E-01 |
| Normal-vs-Female |
4.338600E-01 |
| Male-vs-Female |
7.984800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.067000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.132600E-01 |
| Normal-vs-Age(61-80Yrs) |
5.093800E-02 |
| Normal-vs-Age(81-100Yrs) |
7.160400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.190000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.600040E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.757400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.278600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.984000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.270200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.421000E-01 |
| Classical-VS-Follicular |
9.881900E-03 |
| Classical-VS-Other |
5.973400E-01 |
| Classical-VS-Normal |
8.517200E-01 |
| Tall-VS-Follicular |
6.040500E-02 |
| Tall-VS-Other |
6.016600E-01 |
| Tall-VS-Normal |
8.502200E-01 |
| Follicular-VS-Other |
6.592800E-01 |
| Follicular-VS-Normal |
2.977900E-02 |
| Other-VS-Normal |
5.707800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.996100E-02 |
| Normal-vs-N1 |
2.603000E-01 |
| N0-vs-N1 |
8.685000E-01 |
|
|
